Mercer Global Advisors Inc Pds Biotechnology Corp Transaction History
Mercer Global Advisors Inc
- $39.5 Billion
- Q2 2024
A detailed history of Mercer Global Advisors Inc transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Mercer Global Advisors Inc holds 12,500 shares of PDSB stock, worth $40,375. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,500
Previous 12,500
-0.0%
Holding current value
$40,375
Previous $50,000
28.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PDSB
# of Institutions
76Shares Held
5.45MCall Options Held
155KPut Options Held
61.7K-
Vanguard Group Inc Valley Forge, PA1.41MShares$4.55 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$1.57 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny381KShares$1.23 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA378KShares$1.22 Million0.0% of portfolio
-
Inspirion Wealth Advisors, LLC344KShares$1.11 Million0.18% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $91.9M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...